1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Data
2.3. Validation
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY PRODUCT TYPE
5.1. Introduction
5.2. EDTA Tubes
5.3. Heparin Tube
5.4. Heparin Plasma Separating Tube
5.5. Serum Separating Tube
5.6. Others
6. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY MATERIAL TYPE
6.1. Introduction
6.2. Plastic
6.2.1. Polyethylene Terephthalate
6.2.2. Polypropylene
6.2.3. Polystyrene
6.2.4. Others
6.3. Glass
7. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY END-USER
7.1. Introduction
7.2. Diagnostics Centers
7.3. Hospitals and Clinics
7.4. R&D Centers
8. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Product Type
8.2.2. By Material Type
8.2.3. By End-Users
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Product Type
8.3.2. By Material Type
8.3.3. By End-Users
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Product Type
8.4.2. By Material Type
8.4.3. By End-Users
8.4.4. By Country
8.4.4.1. UK
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Product Type
8.5.2. By Material Type
8.5.3. By End-Users
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. United Arab Emirates
8.5.4.3. Israel
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. By Product Type
8.6.2. By Material Type
8.6.3. By End-Users
8.6.4. By Country
8.6.4.1. Japan
8.6.4.2. China
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Indonesia
8.6.4.6. Taiwan
8.6.4.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. BD
10.2. Cardinal Health
10.3. CHENGDU RICH SCIENCE INDUSTRY CO., LTD.
10.4. FL MEDICAL S.r.l.
10.5. Fresenius Kabi AG
10.6. Greiner Bio One International GmbH
10.7. Thermo Fisher Scientific Inc.
10.8. Kawasumi Laboratories America
10.9. McKesson Medical-Surgical Inc.
10.10. QIAGEN
10.11. SARSTEDT AG & Co. KG
10.12. AdvaCare Pharma